---
title: Explicyte vs STEMCELL Technologies Inc.
slug_a: explicyte
slug_b: stemcell
site: cro
review_signal_gate: closed
canonical_path: /compare/explicyte/stemcell
---

# Explicyte vs STEMCELL Technologies Inc.

Side-by-side profile data from each company listing on this directory.

## Explicyte

- Profile: [/companies/explicyte](/companies/explicyte)

Explicyte — Oncology CRO offering FFPE target discovery, 2D/3D immuno-oncology efficacy and mechanism-of-action assays, and ISO-certified IHC/IF trial biomarker services. Serves biotech and pharma sponsors.

Services: 13. Modalities: 2. Indications: 1. Locations: 1. Certifications: 3. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- Target Identification & Validation
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science

### Modalities

- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Data not yet provided.

## STEMCELL Technologies Inc.

- Profile: [/companies/stemcell](/companies/stemcell)

STEMCELL Technologies Inc. — STEMCELL Technologies develops and sells cell culture media, cell separation systems, instruments, and reagents for life sciences research, plus contract research services including biopharmaceutical testing, cell characterization, toxicity testing, and organoid assays.

Services: 8. Modalities: 1. Indications: 2. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Discovery Research
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Translational Research
- Immunology & Inflammation Services

### Modalities

- Cell Therapy

### Indications

- Oncology
- Immunology

### Phases

- Preclinical (General)
- Discovery

### Sourcing models

- Data not yet provided.